Advances in the study of vasoactive-inotropic score in critically ill patients
10.3760/cma.j.cn121430-20211112-01686
- VernacularTitle:血管活性药物评分在危重症患者中应用的研究进展
- Author:
Li TANG
1
;
Chunying ZHANG
;
Junying LI
;
Yanping DU
;
Teng CAI
Author Information
1. 济宁医学院附属医院心脏重症医学科，山东济宁 272000
- Keywords:
Critical illness;
Vasoactive-inotropic score;
Cardiothoracic surgery;
Sepsis;
Cardiogenic shock
- From:
Chinese Critical Care Medicine
2022;34(11):1213-1217
- CountryChina
- Language:Chinese
-
Abstract:
The degree of hemodynamic support by vasoactive drugs in critically ill patients is often considered one of the markers of disease severity. The sequential organ failure assessment (SOFA), European system for cardiac operative risk evaluation Ⅱ (EuroScoreⅡ), and other scores only roughly quantify the drug support of cardiovascular system. When patients need large doses of vasoactive drugs, the mortality increases accordingly. The vasoactive-inotropic score (VIS) objectively quantifies the degree of cardiovascular support using a simple formula that standardizes the dose of different agents, and it is recommended as a simple, effective, and accurate prognostic indicator. In recent years, there are more and more clinical applications and related studies at home and abroad. This paper reviews the application and progress of VIS score in critically ill patients, providing help for doctors to judge the condition and prognosis of patients and guiding the decision-making of diagnosis and treatment.
